返回 Agenda
Session 1
Speaker(s)
GVP Module Product – or Population-Specific Considerations III: Pregnant and Breastfeeding Women – Where We Are
Viola Macolic Sarinic, DRSC, MD, MSC
European Medicines Agency, Netherlands
Scientific Officer
COVID-19 Pandemic – Challenges and Lessons Learned
Ulla Wändel Liminga, DrMed, MS, RPH
Medical Products Agency (MPA), Sweden
Scientific Director Pharmacology/Toxicology
EMA Pregnancy Strategy
Corinne de Vries, PHD, MA, MSC
European Medicines Agency, Netherlands
EMA liaison official to the US FDA
IMI Conception Consortium: Optimising Data Collection in Pregnant and Breastfeeding Women
David John Lewis, PHD
Novartis Pharma Gmbh, Switzerland
Former Head QPPV PRRC Office, Patient Safety & Pharmacovigilance